Key result
rHuIFN-alpha 1 shows markedly lower human antiviral activity versus other interferons despite unique murine efficacy.
Why the study?
The study aimed to elucidate the nature and relative antiviral activity of different recombinant human interferon subtypes across various cell cultures.
The antiviral activity of recombinant human interferon subtypes varies significantly depending on the cell line used for the assay.
Answers are grounded in this paper and cite their sources.
Requires caution extrapolating murine interferon activity to human cells; leaves open standardized human-cell assays for reliable evaluation.
The phenomenon that rHuIFN-alpha1(D) displays an apparently higher antiviral activity when assayed on bovine cells as compared to human cell lines was applied to the elucidation of the nature of recombinant HuIFN prepared in our institute. These investigations were carried out by using a microtitre test, which defines biological activity as the IFN concentration leading to 50% inhibition of the cytopathic effect of vesicular stomatitis virus (VSV). In addition, the ability of IFN to diminish the reproduction of infectious viruses was monitored. The two methods yielded similar results. With bovine cells, antiviral activities of the same order of magnitude were observed, regardless of the interferon types applied, i.e. rHuIFN-alpha 1, rHuIFN-alpha 2 and human leukocyte interferon. On human fibroblasts, however, rHuIFN-alpha 1 had an apparently 45 to 165 times lower activity than the other two interferons. On human WISH cells, the differences in apparent activity between the respective IFNs were even greater, with factors of up to 212 fold being observed. Still more distinctive were the effects on murine L 929 cells where an antiviral effect could be confirmed only for rHuIFN-alpha 1 whereas the other two interferons proved completely inactive.
No takes yet. Share an insight, caveat, or question.
Tonew et al. (1989) studied this question. rHuIFN-alpha 1 vs. rHuIFN-alpha 2 and human leukocyte interferon was evaluated on 50% inhibition of the cytopathic effect of vesicular stomatitis virus (VSV). rHuIFN-alpha 1 had 45 to 212 times lower antiviral activity on human cells compared to other interferons, but was the only active interferon on murine L 929 cells.
Synapse has enriched 10 related papers. Consider them for comparative context: